Differential effects of cocaine-induced seizures and lethality on M 1-like muscarinic and dopaminergic D1- and D 2-like binding receptors in mice brain

Cellular and Molecular Neurobiology

Volumn 26, Issue 1, 2006, Pages 1-15

  Macêdo, Danielle Silveira ^a   Vasconcelos, Silvânia Maria Mendes ^b   Andrade Neto, Manoel ^a   Fonteles, Marta Maria França ^a   Aguiar, Lissiana Magna Vasconcelos ^a   Viana, Glauce Socorro Barros ^a   De Sousa, Francisca Cléa Florenço ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b University of Ceará State   (Brazil)

Author keywords

Acetylcholinesterase activity; Brain receptors; Cocaine induced lethality; Cocaine induced seizures; Dopaminergic binding sites; Muscarinic binding sites; Prefrontal cortex; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINESTERASE; CARBACHOL; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHYLSCOPOLAMINE; MIANSERIN; MUSCARINIC M1 RECEPTOR; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN HOMOGENATE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEIZURE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACETYLCHOLINESTERASE; ANIMALS; BINDING SITES; BRAIN; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MALE; MICE; N-METHYLSCOPOLAMINE; PARASYMPATHOLYTICS; RECEPTOR, MUSCARINIC M1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPIPERONE; STATUS EPILEPTICUS;

EID: 33745603757     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-006-8565-7     Document Type: Article

References (62)

1. 1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex. Brain Res. 867:250-254.
2. 2 receptors mediate opposite functions in seizure induced by lithium-pilocarpine. Eur. J. Pharmacol. 195:157-162.
3. 1 receptor modulation of pilocarpine-induced convulsions. Neuroscience 34:209-217.
4. Bonhaus, D. W., Walters, J. R., and McNamara, J. O. (1986). Activation of substantia nigra neurons: Role in the propagation of seizures in kindled rats. J. Neurosci. 6:3024-3030.
5. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:3177-3188.
6. Cépeda, C., Buchwald, N. A., and Levine, M. S. (1993). Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. U.S.A. 90:976-980.
7. Cépeda, C., and Levine, M. S. (1998). Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev. Neurosci. 20:1-18.
8. 1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J. Neurophysiol. 87:2324-2336.
9. 1) and other neurotransmitter receptor on corticofugal-projecting pyramidal neurones. Brain Res. 632:86-94.
10. Cuello, A. C., and Sofroniew, M. V. (1984). The anatomy of the CNS cholinergic neurons. Trends Neurosci. 7:74-78.
11. l dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26:83-100.
12. Deransart, C., Riban, V., Lê, B. T., Marescaux, C., and Depaulis, A. (2000). Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 100:335-344.
13. Dhuna, A., Pascual-Leone, A., Langendorf, F., and Anderson, D. C. (1991). Epileptogenic properties of cocaine in humans. Neurotoxicology 12:621-626.
14. Dijk, S. N., Francis, P. T., Stratmann, G. C., and Bowen, D. M. (1995). Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: Implications for Alzheimer's disease. J. Neurochem. 65:2165-2169.
15. Dombrowski, A. M., Jerkins, A. A., and Kauffman, F. C. (1983). Muscarinic receptor binding and oxidative activities in the adult rat superior cervical ganglion: Effects of 6-hydroxy-dopamine on nerve growth factor. J. Neurosci. 3:1963-1970.
16. Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
17. Ferredeli, J. A., Blank, A. C., and Gross, R. A. (1980). Relationship between seizure activity and cyclic nucleotide levels in brain. Brain Res. 200:93-103.
18. Ferri, C. P., Dunn, J., Gassop, M., and Laranjeira, R. (2004). Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in São Paulo, Brazil. Addict. Behav. 29:365-374.
19. 1 receptors and DARPP-32. J. Neurophysiol. 88:3010-3020.
20. Gale, K. (1984). Role of the substantia nigra in the anticonvulsant actions of GABAergic drugs. In Fariello, R. G., Morselh, P. L., Lloyd, K. G., Quesney, L. F., and Engel, J. (eds.). Neurotransmitters, Seizures and Epilepsy, Raven Press. New York, p. 57.
21. 2 receptor gene expression in the rat frontal cortex: Cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7:1050-1063.
22. Gaykema, R. P., Luiten, P. G., Nyakas, C., and Traber, J. (1990). Cortical projection patterns of the medial septum-diagonal band complex. J. Comp. Neurol. 293:103-124.
23. 2 receptors mRNA expression in basal ganglia following kindling. Epilepsy Res. 17:23-29.
24. Grandy, D. K., Zhang, Y. A., Bouvier, C., Zhou, Q. Y., Johnson, R. A., Allen, L., Buck, K., Bunzow, J. R., Salon, J., and Civelli, O. (1991). Multiple human D5 dopamine receptor genes: A functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. U.S.A. 88:9175-9179.
25. Grobin, A. C., and Deutch, A. Y. (1998). Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J. Pharmacol. Exp. Ther. 285:350-357.
26. Hernandez, M.-T., Sauerwein, H. C., Jambaqué, I., Guise, E., Lussier, F., Lortie, A., Dulac, O., and Lassonde, M. (2003). Attention, memory and behavioral adjustment in children with frontal lobe epilepsy. Epilepsy Behav 4:522-536.
27. Higashima, M., Ohno, K., and Koshino, Y. (2002). Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices. Brain Res. 949:157-161.
28. Houser, C. R., Crawford, G. D., Salvaterra, P. M., and Vaughn, J. E. (1985). Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: A study of cholinergic neurons and synapses. J. Comp. Neurol. 234:17-34.
29. 1 region of the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 92:2446-2450.
30. Iadarola, M. J., and Gale, K. (1982). Substantia nigra: Site of anticonvulsant activity mediated by gama-aminobutyric acid. Science 218:1237-1240.
31. Itzhak, Y., and Stein, I. (1992). Sensitization to the toxic effects of cocaine in mice associated with regulation of N-methyl-D-aspartate receptors in the cortex. J. Pharmacol. Exp. Ther. 262:464-470.
32. 2 receptors regulation unilaterally. Abstr. Soc. Neurosci. 17:611.
33. 2 receptors. Life Sci. 49:617-629.
34. 2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J. Physiol. (Lond.) 523:163-173.
35. Kupfermann, I., Kandel, E. R., and Iversen, S. (2000). Motivational and addictive states. In Kandel, E. R., Schwartz, J. H., and Jessell, T. M. (eds.), Principles of Neural Sciences, McGraw-Hill, New York, pp. 998-1013.
36. Lason, W. (2001). Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol. J. Pharmacol. 53:57-60.
37. Lowry, H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:265-275.
38. Macêdo, D. S., Correia, E. E., Vasconcelos, S. M. M., Aguiar, L. M. V., Viana, G. S. B., and Sousa, F. C. F. (2004a). Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell. Mol. Neurobiol. 24:129-136.
39. Macêdo, D. S., Santos, R. S., Belchior, L. D., Andrade-Neto, M., Vasconcelos, S. M. M., Lima, V. T. M., Fonteles, M. M. F., Viana, G. S. B., and Sousa, F. C. F. (2004b). Effect of anxiolytic, antidepressant and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav. 5:852-856.
40. Macêdo, D. S., Vasconcelos, S. M. M., Belchior, L. D., Santos, R. S., Viana, G. S. B., and Sousa, F. C. F. (2004c). Alterations in monoamine levels after cocaine-induced status epilepticus and death in striatum and prefrontal cortex of mice. Neurosci. Lett. 362:185-188.
41. Macêdo, D. S., Sousa, F. C. F., Vasconcelos, S. M. M., Lima, V. T. M., and Viana, G. S. B. (2001). Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor córtex. Neurosci. Lett. 312:129-132.
42. Macêdo, D. S., Vasconcelos, S. M. M., Santos, R. S., Aguiar, L. M. V., Lima, V. T. M., Viana, G. S. B., and Sousa, F. C. F. (2005). Cocaine alters catalase activity in prefrontal córtex and striatum of mice. Neurosci. Lett. 387:53-56.
43. Meldrum, B., and Chapman, A. (1999). Epileptic seizures and epilepsy. In Siegel, G. J., Agranoff, B. W., Albers, R. W., Fisher, S. K., and Uhler, M. D. (eds.), Basic Neurochemistry. Molecular, Cellular and Medical Aspects, Lippincott Williams & Wilkins, USA, p. 758.
44. 2 pK1 values. J. Pharmacol. Exp. Ther. 251:238-246.
45. Oliveira, A. A., Nogueira, C. R. A., Nascimento, V. S., Aguiar, L. M. V., Freitas, R. M., Sousa, F. C. F., Viana, G. S. B., and Fonteles, M. M. F. (2005). Evaluation of levetiracetam effects on pilocarpine-induced seizures: Cholinergic muscarinic system involvement. Neurosci. Lett. 385:184-188.
46. Ritz, M. C., and George, F. R. (1997a). Cocaine-induced convulsions: Pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology 129:299-310.
47. Ritz, M. C., and George, F. R. (1997b). Cocaine toxicity: Concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology 129:311-321.
48. Rockhold, R. W., Carver, E. S., Ishizuka, Y., Hoskins, B., and Ho, I. K. (1991). Dopamine receptors mediate cocaine-induced temperature responses in spontaneously hypertensive and Wistar-Kyoto rats. Pharmacol. Biochem. Behav. 40:157-162.
49. Sackein, H. A. (2004). Convulsant and anticonvulsant properties of electroconvulsive therapy: Towards a focal form of brain stimulation. Clin. Neurosci. Res. 4:39-57.
50. 1 acetylcholine receptor stimulation increases the extracellular concentrations of glutamate and GABA in the medial prefrontal cortex of the rat. Neurochem. Res. 22:281-286.
51. Satoh, K., and Fibiger, H. C. (1986). Cholinergic neurons of the laterodorsal tegmental nucleus: Efferent and afferent connections. J. Comp. Neurol. 253:277-302.
52. 5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. U.S.A. 98:301-306.
53. Smiley, J. F., Levey, A. I., Ciliax, B. J., and Goldman-Rakic, P. S. (1994). D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. U.S.A. 91: 5720-5724.
54. 2-like receptors in rat neostriatum. Pharmacol. Biochem. Behav. 62:15-20.
55. Steketee, J. D. (2002). Neurotransmitter systems of the medial prefrontal cortex: Potential role in sensitization to psychostimulants. Brain Res. Brain Res. Rev. 41:223-228.
56. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2003). Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995-2002, DAWN Series D-24, DHHS Publication No. (SMA) 03-3780, Rockville, MD.
57. Sudha, S., Lakshmana, M. K., and Pradhan, N. (1995). Chronic phenytoin induced impairment of learning and memory with associated changes in brain acetylcholine esterase activity and monoamine levels. Pharmacol. Biochem. Behav. 52:119-124.
58. Szot, P., Riegel, C. E., White, S. S., and Veith, R. C. (1997). Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): Transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin. Mol. Brain Res. 43:233-245.
59. US Department of Health and Human Services. (1985). Institute of Laboratory Animal resources. Guide for the Care and Use of Laboratory Animals, National Research Council, Washington, DC.
60. Ushijima, I., Kobayashi, T., Suetsugi, M., Watanabe, K., Yamada, M., and Yamaguchi, K. (1998). Cocaine: Evidence for NMDA-, β-carboline- and dopaminergic-mediated seizures in mice. Brain Res. 797:347-350.
61. Weinshenker, D., and Szot, P. (2002). The role of catecholamines in seizure susceptibility: New results using genetically engineered mice. Pharmacol. Ther. 94:213-233.
62. 2+. Hippocampus 10:57-63.